Erik Bowman1, Jacob Greenberg2, Michael Garren2, Nalini Guda3, Brian Rajca3, Mark Benson4, Patrick Pfau4, Anurag Soni4, Andrew Walker4, Deepak Gopal4. 1. Division of Gastroenterology & Hepatology, Department of Medicine, University of Wisconsin Hospital & Clinics, 1685 Highland Ave, Madison, WI, 53705, USA. dvg@uwhealth.org. 2. Department of Surgery, University of Wisconsin Hospital & Clinics, Madison, WI, USA. 3. Division of Gastroenterology, Aurora St. Lukes Medical Center, Milwaukee, WI, USA. 4. Division of Gastroenterology & Hepatology, Department of Medicine, University of Wisconsin Hospital & Clinics, 1685 Highland Ave, Madison, WI, 53705, USA.
Abstract
BACKGROUND: Patients with Roux-en-Y gastric bypass (RYGB) develop pancreatobiliary issues after surgery. Endoscopic management via the conventional route with endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) is quite limited due to the altered anatomy. Laparoscopic-assisted ERCP (LA-ERCP) via the excluded stomach has been highly successful. Reported use of laparoscopic-assisted EUS (LA-EUS) is extremely rare. METHODS: A retrospective review was conducted at two tertiary referral centers for cases that involved laparoscopic-assisted ERCP and EUS. Patient demographic data were collected along with data regarding procedure, indication, complications and length of stay. RESULTS: A total of 16 cases involving 15 patients were identified: 11 cases of LA-ERCP and five cases of combined LA-EUS plus LA-ERCP were performed. Four patients had previously undergone failed endoscopy via the conventional route (27 %). There was a 100 % biliary/pancreatic cannulation and intervention rate. There were no endoscopic-related complications. Therapeutic interventions included laparoscopic cholecystectomy, lysis of adhesions, biliary and pancreatic sphincterotomy, biliary and pancreatic stent placement, stone removal including mechanical lithotripsy and EUS biopsy and diagnosis of pancreatic cancer. Average discharge was on postoperative day 3.4. However, 50 % were discharged after 1 day. CONCLUSIONS: LA-ERCP and combined LA-EUS plus LA-ERCP are safe and highly successful diagnostic and therapeutic modalities for a wide variety of pancreatobiliary ailments in RYGB patients.
BACKGROUND:Patients with Roux-en-Y gastric bypass (RYGB) develop pancreatobiliary issues after surgery. Endoscopic management via the conventional route with endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) is quite limited due to the altered anatomy. Laparoscopic-assisted ERCP (LA-ERCP) via the excluded stomach has been highly successful. Reported use of laparoscopic-assisted EUS (LA-EUS) is extremely rare. METHODS: A retrospective review was conducted at two tertiary referral centers for cases that involved laparoscopic-assisted ERCP and EUS. Patient demographic data were collected along with data regarding procedure, indication, complications and length of stay. RESULTS: A total of 16 cases involving 15 patients were identified: 11 cases of LA-ERCP and five cases of combined LA-EUS plus LA-ERCP were performed. Four patients had previously undergone failed endoscopy via the conventional route (27 %). There was a 100 % biliary/pancreatic cannulation and intervention rate. There were no endoscopic-related complications. Therapeutic interventions included laparoscopic cholecystectomy, lysis of adhesions, biliary and pancreatic sphincterotomy, biliary and pancreatic stent placement, stone removal including mechanical lithotripsy and EUS biopsy and diagnosis of pancreatic cancer. Average discharge was on postoperative day 3.4. However, 50 % were discharged after 1 day. CONCLUSIONS: LA-ERCP and combined LA-EUS plus LA-ERCP are safe and highly successful diagnostic and therapeutic modalities for a wide variety of pancreatobiliary ailments in RYGB patients.
Authors: Mitchal A Schreiner; Lily Chang; Michael Gluck; Shayan Irani; S Ian Gan; John J Brandabur; Richard Thirlby; Ravi Moonka; Richard A Kozarek; Andrew S Ross Journal: Gastrointest Endosc Date: 2012-01-31 Impact factor: 9.427
Authors: Raj J Shah; Maximiliano Smolkin; Roy Yen; Andrew Ross; Richard A Kozarek; Douglas A Howell; Gennadiy Bakis; Sreenivasan S Jonnalagadda; Abed A Al-Lehibi; Al Hardy; Douglas R Morgan; Amrita Sethi; Peter D Stevens; Paul A Akerman; Shyam J Thakkar; Brian C Brauer Journal: Gastrointest Endosc Date: 2013-01-03 Impact factor: 9.427
Authors: Jessica M Gutierrez; Howard Lederer; Jon C Krook; Timothy P Kinney; Martin L Freeman; Eric H Jensen Journal: J Gastrointest Surg Date: 2009-09-24 Impact factor: 3.452
Authors: Matthew Connell; Warren Y L Sun; Valentin Mocanu; Jerry T Dang; Janice Y Kung; Noah J Switzer; Daniel W Birch; Shahzeer Karmali Journal: Surg Endosc Date: 2022-01-18 Impact factor: 3.453
Authors: Banreet Singh Dhindsa; Amaninder Dhaliwal; Babu P Mohan; Harmeet Singh Mashiana; Mohit Girotra; Shailender Singh; Gordon Ohning; Ishfaq Bhat; Douglas G Adler Journal: Endosc Int Open Date: 2020-01-22
Authors: Amrit K Kamboj; Victorio Pidlaoan; Mohammad H Shakhatreh; Alice Hinton; Darwin L Conwell; Somashekar G Krishna Journal: Endosc Int Open Date: 2018-01-12